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1.1: INTRODUCTION 
Corneal blindness is one of the main causes of preventable blindness 
and is included in the Vision 2020 program. According to 1999-2000 NPCB 
data, corneal blindness accounts for 0.90% of the total blindness in India(1). 
Gupta et al did a meta-analysis in 2013 and estimated corneal blindness to 
be 0.45%(2). Oliva et al in their publication ‘Turning the tide on Corneal 
Blindness’, included Trachoma, vitamin A deficiency disease in the corneal 
blindness and found it to be responsible for 14% of the 8 million blind 
people in India(3). Of this 14%, 3.9% was from corneal opacities, 1.5% 
from childhood causes (including VADD), 1.4% due to trachoma and 7.3% 
undetermined. 
 Keratoplasty is a time tested surgical treatment for corneal scars, 
decompensation, dystrophies and ectasias. It is also a globe saving 
procedure in cases of severe corneal ulcer. In India annual corneal donations 
are estimated to be between 50600 (EBAI data, 2014-15) to 57944 (NPCB 
data, 2014). The utilisation however is less than 50% and is estimated to be 
around 24300 (EBAI data, 2014-15). As per government projections, we 
need to perform 100,000 corneal transplantation surgeries to reduce the back 
log and address the incidence every year. 
Since 1932 when Filatov gave the concept of moist chamber storage, 
there has been major advances in corneal storage media which allow 
superior preservation of endothelium and prolonged storage time of up to 5 
weeks in organ culture. In spite of these new technology, the most common 
storage method in the developing countries is still the moist chamber and 
MK Medium.  
In the USA most tissues are stored in intermediate term hypothermic 
liquid storage media (most commonly Optisol-GS) and in many European 
nations, organ culture is preferred. The advantage of an intermediate storage 
medium is that it allows easy storage for up 14 days. 
The main function of the corneal storage medium is to maintain the 
viability and functionality of the endothelial cells from collection to 
utilisation. Intermediate chondroitin sulphate media further offer the 
advantage of extended storage for up to 14 days and the stored tissues are 
thinner too. This has several clinical implications – more storage time 
allows more flexible scheduling of surgeries, the surgeon has time to call 
suitable recipients from far away and not worry about the tissue getting 
spoiled. Thinner tissue allows better evaluation pre-operatively, intra-
operative handling is better and also post-operative visual rehabilitation is 
faster. Another advantage of intermediate storage is that it allows 
transportation of tissues. 
The National Cornea Distribution System (CDS) was started in India 
in 2012 through the EBAI-SightLife network(4). Through this system, 
around 1200 tissues were transported in 2014 (source – personal 
communication with EBAI). This is being done using Optisol-GS as the 
intermediate term media.  
There are a few disadvantages of using Optisol-GS – firstly, it is 
expensive (about Rs.2700 per vial) and since it is imported from the USA, 
the availability is limited. The expenses are ultimately borne by the recipient 
family as part of tissue processing charges. 
Cornisol is an indigenous intermediate storage media being 
manufactured by Aurolab, Madurai, India and was introduced in 2012. 
Compared to Optisol-GS it is less expensive (MRP Rs.1300) and being 
manufactured in the country, it is more easily available. According to EBAI 
data this storage medium is being used by over 50 eye banks in the country. 
There has been a positive feedback from the surgeons using the media who 
say that the tissue stored is thinner than in MK medium. 
Till date there has been no in vitro or clinical trial to evaluate the 
performance of Cornisol or compare it with Optisol-GS. A multi-center trial 
was done during development of the product but the data was not published 
(source – personal communication with Aurolab). This is the first study 
being done to see how Cornisol compares to Optisol-GS as a hypothermic 
intermediate storage medium. 
 
 
1.2: HISTORY OF CORNEAL PRESERVATION 
Eduard Zirm performed the first successful human corneal 
transplantation in 1906. The donor was a living 11 year old boy who 
underwent enucleation for penetrating trauma. Freshly enucleated eyes was 
the source of donor tissues for the next three decades. In 1935 V.P.Filatov 
of USSR reported the use of corneas taken from cadaver donors for the first 
time.(5) The globes were enucleated within few hours of death, cleaned by 
washing in brilliant green solution and then stored in tightly closed glass 
bottles with the cornea positioned upwards. He also gave the concept of 
storing them in an icebox and reported eyes which were stored for 20-56 
hours before surgery. He concluded that freshly harvested cadaver corneas 
were as good as living donors. This method revolutionised corneal 
transplantation and Filatov is considered to be the father of eye banking. 
This is how the moist chamber method of storage came to be. The 
storage time was limited to 48 hours. Various methods were attempted to 
increase the storage time like drying, freezing, freeze-drying, adding 
paraffin or formalin. 
When Stocker published the importance of the endothelium in his 
landmark paper in 1953(6), the focus of shifted to developing storage 
medium to preserve the anatomical and physiological integrity of the 
endothelium. 
Using cryopreserved tissues for surgery was first given by Eastcott in 
1954.(7) Other investigators modified and refined the method. In spite of 
being successful clinically, the method was very complex and the method 
did not gain much popularity. 
Then came the landmark moment in 1974 when McCarey and 
Kaufman developed the M-K medium. It was composed of tissue culture 
medium 199 (TC-199), dextran and antibiotics. It allowed corneal storage 
for up to 96 hours at 4oC.(8) This changed the keratoplasty surgery entirely. 
It was no longer an emergency procedure. It became a planned surgery 
allowing the best tissue to be transplanted to the ideal candidate. 
The organ culture method was introduced by Doughman in late 
70s.(9) This method used Eagle’s minimum essential medium, calf serum, 
anti-bacterials and anti-fungals and could store cornea at 37oC for about a 
month. It has been refined over the years and a non-bovine medium is used 
nowadays, chondroitin sulphate and other nutrients are added to preserve 
endothelium more efficiently. 
In the mid-80s the chondroitin sulphate based media started being 
developed. It started with Chondroitin Sulphate Corneal Storage Medium 
(CSM)(10) which was followed by K-Sol(11) and DexSol(12) which was 
made by adding 1% dextran to CSM. Finally Optisol(13) was introduced in 
the early-90s. Since then Optisol has been the most commonly used 
intermediate duration storage medium. 
The exact mechanism by which chondroitin sulphate prolongs 
preservation is not clearly understood but various probable ways have been 
put forth. CS is thought act as an antioxidant and help in maintenance of 
endothelial cell integrity by preventing lipid peroxidation which damages 
cell wall by altering their structure(14). It has been shown that higher 
concentrations of chondroitin sulphate between 2% and 5% are better at 
corneal preservation(15). CS has a role in formation of extracellular matrix 
and maintains physiochemical environment for endothelial function. It may 
also act as a cation-exchange resin and regulate the passage of ions across 
the membrane b forming chelation complexes(16). 
There have been newer media with varying popularity. Chen medium, 
approved in 2000, is an isotonic medium with -hydroxybutyrate instead of 
glucose to reduce lactate formation.(17) There are other newer media 
coming up like Eusol-C(18), Life4oC(19) and Cornea Cold(20). 
 
 
1.3: CLASSIFICATION OF CORNEAL STORAGE MEDIUM 
Based on the duration of storage, the corneal storage media are classified as: 
Short Term Intermediate term Long Term 
Moist chamber K-Sol Cryopreservation 
MK Medium Chondroitin sulphate corneal 
storage medium 
Organ culture 
 DexSol  
 Optisol-GS  
 Eusol-C  
 Chen Medium  
 Life4oC  
 Cornisol  
 
Table 1.1: Different types of corneal storage media 
 
 
 
 
 
 
1.4: VARIOUS METHODS OF CORNEAL STORAGE 
1.4.1: Moist Chamber  
This is the simplest method of corneal storage and still one of the 
leading methods of storage in our country. Whole globe enucleation is done 
and is kept in an air-tight glass bottle. It can store cornea for up to 48 hours 
at 4oC but shorter the storage time, better the surgical outcome.  
Advantages: Simple and inexpensive. Useful in developing countries 
without access to liquid storage media. 
Disadvantage: Short storage time of 48 hours. For the whole duration 
of storage, the endothelium is exposed to post-mortem changes in the 
aqueous like accumulation of waste metabolites, change in pH and ion 
concentration. This ‘aqueous sewer’ as described by McCarey and 
Kaufman(8) can affect the surgical outcome. 
1.4.2: M-K Medium 
The first liquid hypothermic storage medium. It is used for storing 
excised corneo-scleral rim at 2-8oC for 96 hours maximum. 
MK Medium consists of Tissue Culture Medium-199 (TC-199) as 
base, with 5% dextran, HEPES (N 1,2 hydroxyethylpiperazine-N-ethane 
sulphonic acid) and sodium bicarbonate as buffer, phenol red as pH 
indicator and mixture of streptomycin and penicillin (100 units/ml) as 
antibiotic.(8)  
In MK Medium, TC-199 provides the necessary nutrients, dextran 
being an osmotic agent prevents the swelling up of the tissue, the buffers 
maintain a suitable pH and osmolarity of 7.4 and 290 mOsm respectively, 
and the antibiotics prevent microbial contamination. 
1.4.3: Optisol-GS 
Introduced in 1991 by Chiron Ophthalmics, Optisol is the most 
popular chondroitin sulphate based intermediate duration media. It is a 
hybrid of K-Sol and DexSol in composition and can store corneal button for 
a maximum of 14 days. Now it is marketed by Bausch and Lomb. 
Optisol contains Tissue Culture Medium-199 (TC-199), Earle’s 
Balanced Salt Solution and Minimum Essential Medium as the base 
component. 2.5% Chondroitin sulphate(CDS), 1% dextran-40(14). The high 
concentration of CDS and dextran act together to give greater deturgescence 
to the stored tissue. Like MK Medium HEPES and bicarbonate act as 
buffering agents. Optisol contains additional components to increase 
endothelial viability. ATP precursors like adenine, adenosine and inosine 
are added to supplement the limited stored ATP. Cobalamine is added as 
enzymatic co-factor and ascorbic acid acts as antioxidant(12). Other 
micronutrients like amino acids, sodium pyruvate, L-glutamine, 2-
mercaptoethanol are also present. 
Constituent Optisol DexSol K-Sol 
Base medium TC-199 and MEM MEM TC-199 
Chondroitin Sulphate 2.5% 1.35% 2.5% 
Dextran 40 1% 1% 0 
HEPES buffer Yes Yes Yes 
Gentamicin sulphate Yes Yes Yes 
Non-essential amino 
acids (mmol/L) 
0.1 0.1 0 
Sodium bicarbonate Yes Yes Yes 
Sodium pyruvate 
(mmol/L) 
1 1 0 
Antioxidants Yes Yes No 
 
Table 1.2: Comparison of CDS based intermediate media. Optisol 
was developed as a hybrid of K-Sol and DexSol. [From Kaufman et al 
(14)] 
 
Initially Optisol had only gentamicin sulphate 100mg/l as the 
antibiotic. But it provided limited prophylaxis against gram-positive 
organisms. A study reported the most common organism for post-
keratoplasty endophthalmitis to be gram-positive cocci(21). To address this 
streptomycin 200mg/l was added to Optisol in 1993 and to denote the 
presence of two antibiotics, the name changed to Optisol-GS (22). 
Streptomycin was chosen because of its previous use in MK medium which 
proved its success and clinical safety. Also, it was much more stable than 
vancomycin (97% vs. 37%) as solution for up to one year. 
The only limitation of Optisol-GS is its inability to preserve 
epithelium efficiently beyond 1 week(23). 
1.4.4: Eusol-C 
This is an entirely synthetic storage medium which can store tissues 
at 4oC for 14 days(24).There is no chondroitin sulphate; only dextran is used 
as osmotic agent. It contains only gentamicin as the antibiotic and phenol 
red pH indicator. Being synthetic, it can be stored in room temperature 
before use and can tolerate relatively higher temperature during 
transportation(23). 
1.4.5: Life4oC 
It is a new FDA approved intermediate storage medium which is 
supposedly better than Optisol-GS for corneal preservation. Its composition 
is similar to that of Optisol-GS. Extra components include L-glutamine, 
recombinant human insulin which helps in better nutrient uptake by the cells 
and reduced glutathione as a powerful antioxidant. There are also additional 
membrane stabilizers, antioxidants and micronutrients(23)(25). In an 
internal study by the manufacturer Numedis, Life4oC was statistically 
significant in maintaining endothelial cell density and keratocyte 
survival(26). Also it had greater tissue deturgescence and stored tissues 
were significantly thinner than in Optisol-GS. Unlike other storage media it 
comes in 30ml vials and there is a specialized transport-cum-viewing 
chamber available. This increased volume is able to supply more nutrients 
to the endothelium and also offers better dilution of toxic metabolites(25). 
1.4.6: Cryopreservation 
It is the only method which can theoretically store cornea indefinitely. 
Though this method was described in the 50s, it is not very popular because 
of the technical complexity and mainly because of freezing injury to the 
cells. There are reports on higher endothelial cell loss and primary graft 
failures with cryopreserved tissues than liquid hypothermic media(27). 
Refinements are being made like storing tissues in dimethyl sulphoxide 
(DMSO) which is a cryo-protectant or using vitrification which is an ice-
free method(28). 
1.4.7: Organ Culture 
This method was first described by Doughman in 1972 where he 
demonstrated storage of tissue for 5 weeks at 34oC with good endothelial 
function. The longer storage period allows screening for prion diseases and 
quarantining tissues for microbial contamination. However due to technical 
difficulty and high maintenance, it is used only in certain European nations 
especially in the Netherlands. There are two methods currently in use – the 
Minnesota method and the Dutch method(16). Eurosol (Bausch and Lomb) 
is a serum-free organ culture medium approved for use in Europe(23). 
 
 
 
1.5: SPECULAR MICROSCOPY 
 
The specular microscope (SPM) is a specialized microscope which is 
used to visualize and record the corneal endothelium. And using in-built 
computer programs we can quantify various parameters of the endothelial 
structure. 
Vogt in 1918 first visualised the endothelial layer with a slit lamp 
using the method of specular reflection and described it as ‘a graceful 
honeycomb., Later in 1968 David Maurice made the first specular 
microscope.(29) Over the years it has evolved from contact, wide field type 
to non-contact, narrow field and higher resolution type.  
1.5.1: Principle of Specular Microscopy:  
In normal microscopy we look at light transmitted through the 
specimen but in specular we are more interested in the light that is reflected. 
When light strikes a surface, it can be reflected, transmitted (refracted) or 
absorbed. Specular reflection or mirror-like reflection happens when the 
angle of incidence is equal to the angle of reflection. This image is captured 
by the SPM.(29) 
Light striking the normal cornea is mostly transmitted but a small 
fraction is reflected at interfaces of different optical density (or refractive 
index) e.g. tear-epithelial interface, endothelium-aqueous interface. At the 
endothelium-aqueous interface about 0.022% of the light is reflected 
back.(30) The greater the difference between the refractive indices, the more 
is the amount of reflected rays. The area of the specular reflex also depends 
upon the radius of curvature of the reflecting surface. Also it is important to 
know if the area being images is representative of the entire cornea. For 
example, one can image an area of focal injury in an otherwise normal 
cornea and the abnormal counts will get extrapolated to the whole area.  
There are certain criteria to obtain the ideal specular image. The 
endothelium must be at the accurate distance for the focus of objective lens. 
The part of the endothelium being imaged must be perpendicular to the 
optic axis of the objective lens.  
The quality of the image depends on the numerical aperture of the 
objective lens, how clean the lenses are. Another important factor is the 
presence of glass or plastic and storage media between the lens and tissue. 
Although transparent, these can lead to considerable distortions(31). A 
viewing chamber can reduce this problem to some extent. 
1.5.2: Types of Specular Microscopes: 
1: Contact and non-contact depending on the nature of the objective lens. 
The image resolution depends on the numerical aperture of the objective 
lens. This is a bit higher with contact objective lenses thus giving a sharper 
image(31). They also reduce the ocular movement so the image has less 
motion artifacts. Contact SPMs can be used to image the epithelium and 
stroma too and gives accurate pachymetry values. But being more practical 
and easy to use, the non-contact ones are used more commonly. 
2: Clinical and Eye-bank specular microscopes. 
1.5.3: Eye Bank Specular 
The eye bank SPM is little different from the clinical variety. It 
allows in-vitro analysis of corneas through the vial of the storage media. 
Unlike in patients, the cornea is viewed directly from the endothelial side. 
The stage has a holder for the vial which can be moved in X-Y axis and also 
can be tilted to allow maximum specular reflection(32). 
Older contact varieties could be used to image the endothelium with a 
whole globe but modern ones are non-contact to allow imaging of cornea in 
stored media. 
It is a must to warm the cornea to room temperature before doing 
specular imaging. At storage temperature of 2-8oC the endothelial pump is 
relatively inactive leading to tissue oedema and there is loss of normal 
smoothness. Rewarming time may vary from 45 minutes to 2 hours(31). 
 
1.5.4: Specular Analysis 
Specular microscopic images can be interpret in two ways: 
1. Qualitative 
2. Quantitative 
Qualitative analysis: Here we look at the appearance of cell borders, cell 
shape, intra-endothelial and inter-endothelial abnormalities.  
A normal specular image will show endothelial cells as bright 
hexagons with dark cell borders. Cells are of uniform size and shape with no 
abnormal bright or dark areas. The cell density is between 2000-3000 
cells/mm2 with more than 60-70% hexagonal cells. 
The light falling on the cell borders are reflected in such a way that 
they are not received by the SPM and are seen as dark, thin lines whereas 
the rays falling on the surface of the cell undergo orderly reflection forming 
a bright area. Normally the borders form a hexagon with three lines meeting 
at 120o. In pathological conditions there may be rounding of the borders 
secondary to oedema, trauma or aging.(33) 
Cell shape variation is a part of normal aging. With decreasing 
numbers the cells increase in size and associated shape alterations take place. 
Abnormal cells can appear as stretched, scalloped, rounded, square or 
triangular.(33) Injured endothelium can show signs of healing like 
enlargement of cells to fill-up the damaged areas or cell coalescence where 
the cell borders between two cells disappears slowly as they merge 
together.(31) 
Guttae are excrescences of the Descemet’s Membrane. They appear 
as dark with central bright spot with abnormally shaped surrounding cells. 
These excrescences and coalesce and hinder visualisation of the 
endothelium. Hassall-Henle warts are also excrescences seen in the 
peripheral cornea. These are usually dome shaped with normal endothelial 
cells. Bacteria and inflammatory cells appear as small bright twinkling 
objects with changing shape and position. 
Quantitative analysis: Here we use in-built computer programs to 
automatically or semi-automatically calculate various endothelial cell 
features. The various parameters which are looked at are: 
1. Endothelial Cell Density (ECD) – number of cells per square millimetre 
(cells/mm2) 
2. Mean or Average Cell Area – measured as um2 
3. Coefficient of Variation (CV) – Variations in the areas of different cells 
4. Percentage Hexagonality (6A) – percentage of cells that are perfectly 
hexagonal. 
1. Endothelial Cell Density: This can be counted in a number of ways. 
a. Fixed frame analysis – A box of known area is overlayed on the specular 
image and number of cells inside are counted. Cells that are partially in the 
given area are counted as half. The total is then multiplied by number 
depending on area selected. This method is very error-prone because of the 
‘border cells’ or cut-off cells and is rarely used nowadays. 
b. Variable frame analysis – A variable shape of contiguous cells first 
outlined, then cells in this defined area are counted. The selected area is 
determined by computer planimetry. Once the area is known, the ECD is 
calculated. This is superior to fixed frame method as only complete cells are 
counted and there is no confusion regarding partially included cells. This is 
the most accurate and reliable semi-automatic method of counting.(31) 
However, this method does not provide very accurate data about the cell 
size distribution as doing it for a large number of cells is very tedious. 
c. Center method – A newer method where only the center of the cells are 
marked. The computer identifies adjacent cells and performs the 
calculations. It is important to mark at least a hundred cells because cells 
without adjacent ones maybe discarded while computing. 
Center-flex method is a hybrid of variable frame analysis and center 
method where the user outlines the borders of cells and marks their centers. 
d. Corner method – Each cell is marked by identifying the six corners. The 
software connects these dots and determines the area and ECD. This method 
was used initially. 
e. Comparison to fixed pattern – The image is compared to various 
specular images of known ECD values and closest match is considered as 
the count. It gives a very rough estimate. 
2. Coefficient of Variation: CV is a numerical representation of 
polymegathism. Polymegathism refers to the variations in cell sizes.  
CV = SD cell area/Mean cell area in µm
2 
3. Percentage Hexagonality (6A): Pleomorphism or Polymorphism refers 
to the variations in cell shapes. 6A is a numerical way to represent that. 
Polymorphic cells have less or more than six sides and are therefore less 
hexagonal. Also, CV and 6A are inversely related. Change in cell size is 
almost always associated with change in shape. So more CV would mean 
less hexagonality. 
In quantitative analysis, the ECD is not the only parameter to look at. 
Polymorphism and polymegathism are believed to be sensitive indicators of 
endothelium under stress. A high CV and low 6A indicates unusable 
relationship between neighbouring cells which can lead to loss of pump and 
barrier function. 
Modern SPMs have completely automated counters which outline and 
count cells automatically in a given area and generate the morphometric 
reports. The intelligent program is able to identify and exclude areas of poor 
or unfocussed image quality. The number of cells counted is much more 
than manual method thus giving better statistical results. It is also able to 
give additional data like a cell density histogram, give overlays showing 
abnormal cell sizes in different colours. And all that is done in less than a 
minute(31).  
Accuracy of the quantitative analysis depends on – image quality, 
how well the sampled area represents the whole cornea, technician’s ability 
to identify cells and borders and mark accurately. Common errors are 
missing cells, double counting and not being able to identify the borders 
correctly. Automated counters should always be supervised by a trained 
personnel with knowledge of the cornea so that the above errors can be 
minimized. For good statistical output, there should be only a single dot 
marking the cells placed exactly in the center of the cells.  
The age of the cornea is of less importance than the appearance of the 
cell in determining the health and functional reserve of the tissue. So instead 
of determining suitability based on age alone, it is very important to do a 
SPM evaluation of old donor corneas. 
1.5.5: Application of Specular Microscopy 
1. Donor cornea evaluation in eye bank and selecting tissues for optical or 
endothelial surgeries. 
2. Penetrating Keratoplasty – cell loss happens more than normal but more-
or-less at a steady rate 
3. Endothelial Keratoplasty – Initial high loss of cells at 6-12 months but 
thereafter less than that of penetrating keratoplasty. 
4. Fuchs’ endothelial corneal dystrophy- documenting progression 
5. Cataract surgery – pre and post-op images to study the cells loss during 
various surgical procedures 
6. ICE (irido-corneal-endothelial) syndrome shows a reversal appearance 
with black borders and white central areas. 
7. PPCD (posterior polymorphous corneal dystrophy) – differentiating from 
ICE 
8. Documenting corneal guttae 
9. Physiological ECD loss with aging at about 0.5 to 1% per year 
10. Keratoconus – shows elongated cells with long axis towards the direction 
of apex of cone. 
11. Document endothelial damage following intraocular inflammation, 
trauma, vitreous touch, in contact lens users, in diabetics etc. 
1.6: GROSS AND SLIT-LAMP EXAMINATION OF THE 
DONOR EYE 
The functioning of the eye bank can be broadly grouped as potential 
donor screening, procurement, processing and preservation, evaluation and 
distribution. 
The aim of detailed evaluation of donor tissue is to identify which 
tissues are suitable or unsuitable for surgery and to further group the 
suitable tissues for different types of keratoplasty technique. This is to 
ensure that this precious donation is utilised fully by the ideal recipient. 
1.6.1: Donor screening and general examination 
Donors are of two types - voluntary donors where the donor family 
contacts the eye bank and donors whose families are counselled through a 
hospital corneal retrieval program (HCRP). 
Before going ahead with the actual procedure it is important to do the 
following. Identify the donor and confirm the death. Take written informed 
consent from the family members. Eye donation pledge cards are not a 
substitute for consent. Document the cause of death. Take detailed ocular 
and medical and surgical history especially about intraocular and refractive 
surgeries, contact lens use, medical comorbidities, malignancy, history of 
ventilator support, blood transfusion etc. A general examination of the 
whole body should be ideally performed looking for signs of high-risk 
behaviour.  
1.6.2: In situ examination of the eye 
The eye and adnexa should be examined carefully before collection 
preferably with a pen torch. Examination should focus on looking at signs of 
infection, details of intraocular surgery especially lens status, icterus of the 
sclera. Unlike in whole globe enucleation, a detailed slit lamp examination 
cannot be done with in situ excisions. Therefore the onsite gross 
examination becomes even more important. Also it is important to note 
corneal folds and oedema before placing in storage medium which can 
reverse these findings(34). 
Collection of the eye can be done by the followed techniques: 
1. In situ corneoscleral rim (CS rim) excision with immediate transfer to 
storage media (short or intermediate-term) 
2. Whole globe enucleation with moist chamber storage 
3. Whole globe enucleation followed by CS rim preparation in the eye bank 
and storage in 
a. Liquid hypothermic media – short or intermediate storage 
b. Organ culture 
c. Cryopreservation 
Whole globe enucleation and CS rim preparation have their advantages and 
disadvantages. In situ technique is gaining popularity recently. 
Advantages of in situ excision: 
1. More cosmetically acceptable. This sometimes helps in winning over the 
donor family while counselling. 
2. Death to storage time in moist chamber is decreased as tissues are 
immediately kept in storage media.  
3. The contact time of the endothelium with the toxic aqueous is decreased. 
Disadvantages: 
1. In most cases only a pen-torch examination is done at the site. If the 
tissue is unsuitable based on slit-lamp examination alone, then the cost of 
tissue preservation, disposables can be saved which is not possible with 
in situ collection. 
2. Whole globes not suitable for surgery can be used for research and 
surgical training more widely than CS rims. 
3. Inexperienced technicians can cause more damage to the tissue while 
doing an in situ excision. 
 
 
1.6.3: Gross examination 
On gross in situ examination with pen torch the following findings 
should be noted: 
1. Epithelial oedema and epithelial defects from exposure or trauma 
2. Stromal opacities – arcus senilis, central scars, infiltrates 
3. Stromal oedema – clarity of cornea and number and severity of deep 
folds 
4. Abnormal corneal shape – keratoconus, micro or megalocornea 
5. Status of the anterior chamber – formed, shallow or flat; anatomical 
abnormality; turbidity of the aqueous humour 
6. Evidence of surgery on the cornea, phakic or aphakic, evidence of iris 
laser 
7. Condition of the globe – firm, soft or collapsed 
With the whole globe the posterior part of the eyeball can also be 
examined. Traumatic corneal abrasions, collapsed globe, scleral perforation 
are evidence of improper enucleation technique.  
1.6.4: Slit lamp examination 
Slit lamp examination of the whole globe or CS rim is the most 
important step of quality control in an eye bank. A viewing chamber allows 
much better optics and easier evaluation. Most storage vials are transparent 
glass or plastic and allow examination through the bottom, albeit a bit 
challenging. A vial holder with mirror attachment on the slit lamp is 
recommended. Whole globe examination is done in the moist chamber jar 
with lid open and the tissue brought forward. A viewing brace is used to 
clamp the vial in position. 
First use low magnification with diffuse or wide slit beam at 45o to 
examine. Then use high magnification with slit beam to systematically study 
all the layers of the cornea from anterior to posterior. And to complete the 
examination use coaxial position and retro-illuminate the tissue. This can 
sometimes reveal defects or opacities which may have been missed on 
oblique slit(34). 
Corneal epithelium: Look for microcystic oedema, abrasions, epithelial 
defects and foreign bodies. In areas of epithelial defect rule out Bowman’s 
or stromal injury. 
Corneal stroma: Stromal opacities are examined in detail to define the 
extent, depth, location and appearance of the opacity and dystrophies are 
excluded. It is vitally important to differentiate between opacities and 
infiltrates. Infiltrates appear as slate grey without adjacent oedema whereas 
infiltrates have a yellowish white look with surrounding stromal oedema. 
Deep stromal folds can be seen along with stromal oedema. 
Corneal endothelium: Before doing a SPM imaging slit-lamp examination 
is a fast and efficient method to evaluate the endothelium. A meticulous 
examination should be done to look for intactness of the endothelial layer 
and DM, guttata, Descemet’s tears, stress lines and fractures and endothelial 
vesicles. 
Anterior chamber: A crystalline appearing aqueous indicates that the globe 
had been frozen and such tissues ideally should not be used. Examine the 
iris for signs of trauma, surgery, tumours, and lasers. Note the lens status. 
Excised corneoscleral rim: Make sure the rim is at least 2 mm all around 
so that it fits well on an artificial anterior chamber. A wide area of sclera 
can be used for scleral grafts. 
Storage media: It is also important to examine the state of the media. 
Clouding and colour change are indicative of infection or major metabolic 
changes. In case there is a lot of debris, the tissue should be transferred to a 
new vial. 
1.6.5: Specular microscopy 
This is the most important investigation to be done before distributing 
tissues. The technician should be well trained in techniques of counting cells. 
Tissue should be allowed to rewarm adequately before imaging. 
 
Features of abnormal endothelium on specular microscopy: 
a. Cell density of <1500 cells/mm2 
b. Severe polymegathism or pleomorphism 
c. Corneal guttata 
d. Abnormally shaped cells 
e. Abnormal single-cell defects 
f. Large areas of oedema 
g. Presence of bacteria or inflammatory cells 
h. Presence of ghost vessels in stroma 
The eye bank donor proforma consists of details regarding the time and 
cause of death, death to enucleation time, refrigeration time if any, transport 
time and time in moist chamber. Details of slit lamp and specular 
microscopy are attached. The tissue is then graded as per the eye bank 
protocol.
1.7: METHODS OF ASSESSING ENDOTHELIAL VIABILITY 
A living endothelium is absolutely necessary for normal corneal 
function. Therefore it is important to assess the ability of the storage method 
to preserve endothelial viability. Here are few methods which are used to 
directly or indirectly assess endothelial viability.(35)  
1. Staining methods: 
a. Trypan blue alone or with Alizarin Red – stains nuclei of cells with 
damaged membrane while alizarin stains the intercellular membranes 
b. Nitro-blue Tetrazolium – Enters and stains cells with damaged 
membrane. 
c. Acridine orange/ ethidium bromide – arcidine orange enters viable cells 
and gives green fluorescence whereas non-viable ones stain with ethidium 
bromide and has red fluorescence. 
Other methods include lissamine green, Evans blue, indocyanine green and 
rose bengal(36). 
2. Temperature Reversal: The change in corneal thickness is noted as 
tissue is rewarmed from cold storage. Reactivation of the endothelial pump 
makes the tissue thinner thus indicating viable function. 
3. Bicarbonate Flux: The bicarbonate flux across the endothelium is related 
to the outward flow by active endothelial pump action and inward flow 
limited by the barrier function. This is measured using radio-isotope labelled 
bicarbonate. 
4. Electron Microscopy 
a. Transmission Electron Microscopy: To study the cellular organelles. 
b. Scanning Electron Microscopy: To study the integrity of the cell 
membrane 
5. Specular Microscopy: Allows both qualitative and quantitative analysis 
of the endothelium. The morphometric analysis can be done at various 
stages to note change over time. 
6. Enzyme release: Enzymes released give an indirect idea about the 
metabolic activity. Lactate dehydrogenase and acid phosphatase levels in 
the media indicate about the endothelial metabolism. 
7. Nuclear Magnetic Resonance: Uses NMR to detect high and low energy 
phosphates which indirectly point at energy consumption and metabolism. 
8. Redox Fluorometry: This uses the principle of measuring metabolism 
through the levels of relative concentration of reduced pyridine nucleotides 
and oxidized flavoproteins. 
9. Intracellular glutathione oxidation-reduction status 
10. Measuring the uptake of radio-labelled metabolites 
11. Measuring oxygen consumption 
1.8: ENDOTHELIAL VIABILITY BY HISTOPATHOLOGY 
Specular microscopy gives only a picture of the endothelial 
honeycomb. While it is sufficient to assess the endothelium by looking at 
the ECD and the variations in cell shape and size, we need something more 
if we want to assess the vitality of these cells. Histopathological analysis is 
one such method. 
Trypan blue was used as a vital stain to determine areas of endothelial 
damage since early 1970s. Vital staining of the corneal endothelium by 
using dual stains was first described by Spence and Peyman in 1976.(37) 
They used a combination of 0.25% trypan blue and 0.2% alizarin red-S to 
stain rabbit corneal endothelium. This method combined the vital staining 
property of trypan blue with alizarin red’s property to stain the intercellular 
membrane.  
Later in 1977 Sperling published his findings using similar 
method.(38) Taylor and Hunt in 1984 in their article titled “Dual staining of 
corneal endothelium with trypan blue and alizarin red S: importance of pH 
for the dye-lake reaction” showed that adjusting the pH of alizarin red to 4.2 
gave best staining of the intercellular membranes and using glutaraldehyde 
as fixative preserves the stained tissues.(39) Over the years there has been 
further refinements to this method in regards to the dye concentration and 
duration of staining. Singh et al concluded that 0.3% trypan blue for 1 
minute followed by 0.2% alizarin red for ½ to 1 minute is ideal in 1986(40) 
and recently in 2012 Park et al demonstrated 0.4% trypan blue and 0.5% 
alizarin red for best staining outcomes.(41) 
Principle of Staining 
Trypan blue was initially used as the vital stain for looking at areas of 
endothelial damage. It stains the cells in which the permeability of the cell 
membrane is increased. Healthy cells are not outlined and only dead or 
partially damaged cells are stained. Grid counting to quantify is therefore 
not possible.(37) 
This is where dual staining is advantageous. Both stains are 
impermeable to healthy cells with intact cell membrane. Alizarin red stains 
the intercellular borders and trypan blue enters cells with damaged 
membrane and stains the cytoplasm and nuclei. 
After staining, the following patterns are seen. A healthy cell appears 
as a clear area with the hexagonal borders stained with alizarin. Damaged 
cells which are attached to the Descemet’s membrane have outlines stained 
with alizarin along with nuclei stained dark with trypan blue. Whereas, 
damaged cells which are dislodged from the Descemet’s membrane show 
areas of drop out with bare DM stained diffusely with both alizarin and 
trypan blue giving a pink-red colour.(37) 
Due to the natural curve of the cornea, it is difficult to sharply focus 
the entire area under the microscope. While viewing, some areas will be out 
of focus. The dense staining tends to fade and decrease in contrast within an 
hour. To prevent that, one can fix the tissues with glutaraldehyde. Fixation 
also helps flatten the cornea allowing a larger to be focussed. 
This is a superior method than staining with trypan blue only. Since 
all cells, healthy, dead or damaged and areas of drop out are outlined clearly, 
a grid count or computer program can be used to accurately quantify the 
damage. 
 
 
 
 
 
 
 
 
1.9: REVIEW OF LITERATURE 
Review of literature was done with PubMed search. Keywords used 
were Optisol and Optisol-GS, Cornisol, corneal endothelial viability and 
articles relevant to this study were considered. Cornisol keyword did not 
return any results. 
Kaufman et al in the article Optisol Corneal Storage Medium(14) 
compared Optisol with DexSol in an in vitro method. 15 pairs of human 
corneal tissues were compared in three groups – storage at 4oC for 2 weeks, 
room temperature storage at 26oC for 1 to 4 days and hypothermic storage 
with temperature reversal analysis. Finally tissue thickness and scanning 
electron microscopy was done for all tissues and graded as per a 
morphological scoring system. They found that Optisol stored tissues stored 
at 4oC for 2 weeks showed better morphology than DexSol stored tissues 
and were significantly thinner. However, for tissues stored at 26oC there was 
no difference between the two media. The investigators concluded that 
Optisol was superior to DexSol for intermediate storage at 4oC which would 
allow more flexible surgical scheduling and more appropriate tissue for the 
patient and reduce tissue wastage. 
Lass et al in their article A Randomized, Prospective, Double-Masked 
Clinical Trial of Optisol vs. DexSol Corneal Storage Media(12) also 
compared Optisol with DexSol in a clinical trial. 31 pairs of human corneal 
tissues were stored at 4oC, one in Optisol and its paired tissue in DexSol for 
a period of 24 to 134 hours. Preoperative specular microscopy was done. 
They were then transplanted to patients, each pair operated by the same 
surgeon using same technique within 8 hours of each other. The patients 
were meticulously matched for age, gender, underlying corneal pathology, 
statues of cornea and lens status in 42% to 82% of cases. Intra-operatively 
the corneal thickness was measured with ultrasound pachymetry. Lysosomal 
enzyme release assay was done with the cut portion of the corneal button. 
Post-operative slit lamp, specular microscopy, pachymetry and applanation 
tonometry was done at 3, 6 and 12 months. There was one graft failure in 
the Optisol group, rest all grafts were clear in both groups at one year. 57% 
patients in Optisol group and 38% patients in DexSol group had CDVA of 
20/40 or better. Keratometric and refractive measures did not reveal any 
significant difference between the two groups. Intraoperative tissue 
thickness was significantly lower in the Optisol group (p=0.0001) but did 
not vary post-operatively. Serial specular microscopy did not show any 
significant differences in endothelial cell loss or morphometric parameters 
between the two media. They hypothesized that Optisol stored tissues are 
thinner probably because of chondroitin sulphate, better post-storage tissue 
deturgescence and due to a greater loss of endogenous glycosaminoglycans. 
Both groups had rebound swelling in immediate post-operative period 
probably due to penetration of the media in the stroma which attracts water. 
The lysosomal enzyme release which is directly related to cell viability was 
found to be significantly lower in the Optisol group. Therefore they 
concluded that the advantage of Optisol over DexSol in only apparent 
during storage and surgery. There is less autolysis during storage and the 
thinner tissue allows better tissue evaluation pre-operatively with slit lamp 
and specular microscopy. Also, thinner tissue is easier to handle intra-
operatively and gives earlier visual rehabilitation post-operatively. 
Lindstrom et al in the article Optisol Corneal Storage Medium(13) 
compared Optisol with DexSol, K-Sol and McCarey-Kaufman medium. 
This was an extensive study which combined both in-vitro studies and 
clinical trial using human and rabbit corneas. Three phases of studies were 
done – in vitro examination of endothelial preservation in terms of 
metabolism, structural changes and thickness; in vivo evaluation of 
epithelial toxicity; and clinical outcome. For the in vitro analysis tissue 
cultured human endothelium was stored in Optisol or DexSol and the 
mitotic activity measured with radiolabeled thymidine. Rabbit cornea tissues 
were randomly divided and stored in MK-medium, Optisol and DexSol. 
Specular microscopy and ultrasound pachymetry were done. Additionally, 
cell membrane potential was measured with microelectrodes and redox 
fluorometry was done to measure metabolic function. Two human corneas 
each were stored for 2 weeks at 4oC in DexSol or four variants of Optisol 
with different concentrations of chondroitin sulphate. Corneal thickness was 
measured at intervals and finally endothelial cell viability was assessed 
histologically with Alizarin red-S and trypan blue staining. Human corneas 
not suitable for surgery were stored in Optisol and DexSol and both 
scanning and transmission electron microscopy done. In vivo studies 
included checking for corneal toxicity by instilling Optisol drops in rabbit 
corneas and histopathological analysis done. Finally an open-label clinical 
trial was done where 51 tissues stored in Optisol were transplanted, intra 
and post-operative pachymetry was done along with post-operative specular 
microscopy. They found that Optisol incubated tissues had significantly 
increased mitotic activity which was found to be due to adenosine 
component in the media. Rabbit tissues stored in Optisol were significantly 
thinner, the specular images showed lesser swollen endothelial cells with 
fewer cytoplasmic vacuoles. The membrane potential was stable across all 
the media. Human tissues stored in 2.5% chondroitin sulphate was found to 
be thinnest than other concentrations. Histological examination showed 
intact endothelium in all the media with Descemet’s staining along areas of 
stromal folds or stress lines. Electron microscopy was comparable till day 7 
but by day 14 DexSol sored tissues had lost all cellular integrity. Rabbit 
eyes instilled with Optisol did not show any histological abnormality. From 
the clinical trial, 93% patients had clear graft at three months, endothelial 
cell loss was about 5% (± 18.4%) at three and 11.5% (± 14.4%) at six 
months. This study, like the previous ones, concluded that the main 
advantage of Optisol is thinner tissues during storage and surgery. While the 
exact mechanism is not known it is due to better endothelial cell function 
and high concentration chondroitin sulphate. 
There are a few clinical studies comparing Optisol-GS with Chen 
medium which is a non-lactate containing, non-chondroitin sulphate 
medium.  
Nelson et al did an in vitro comparison between the two and reported 
the results in the article In Vitro Comparison of Chen Medium and Optisol-
GS Medium for Human Corneal Storage(17). They found that there was no 
significant difference between the tissues stored in the media in terms of 
endothelial cell density, coefficient of variation and percentage hexagonality. 
Electron microscopy showed intact endothelium for all tissues. There was 
no difference in percentage of apoptotic keratocytes and TUNEL-positive 
cells were not correlated with storage time. They concluded that both the 
media were equally effective for intermediate term corneal storage.  
In another study comparing Chen media with Optisol by Bourne et al 
titled Comparison of Chen Medium and Optisol-GS for Human Corneal 
Preservation at 4oC a clinical study was undertaken(42). 32 surgeries were 
done with 15 tissues stored in Chen Medium and 17 in Optisol-GS. Specular 
images were taken pre and post-operatively. Corneal thickness and specular 
morphometric parameters were compared between the two groups serially 
over one year follow-up. They found no statistical significance in 
endothelial cell loss, coefficient of variation and hexagonality. Endothelial 
cell loss at 2 months post-op was significantly correlated with storage time 
in both the groups. In conclusion, tissues stored in Chen Medium was not 
different from Optisol-GS over 1 year follow-up. 
Kanavi et al has published a recent study titled Comparing 
quantitative and qualitative indices of the donated corneas maintained in 
Optisol-GS with those kept in Eusol-C(18). The authors compared 90 pairs 
of corneal tissue in an in vitro method. Serial slit lamp examination and 
specular microscopy was done. Tissues were graded as per eye bank 
guidelines. There was no significant difference in slit lamp features and 
specular parameters between the tissues stored in either groups. The authors 
concluded that there is no superiority of Optisol-GS over Chen medium in 
preservation of corneas in terms of corneal rating, stromal oedema, 
Descemet’s folds and endothelial cell indices. 
Pham et al published an in vitro comparison of Optisol-GS and 
Life4oC where they looked at the specular image quality of tissues stored in 
either media. They studied 25 pairs of tissues with serial specular images 
taken during thawing from 2-8oC to room temperature. The images were 
graded to a classification system. They found that for good quality specular 
images Optisol-GS tissues required significantly longer thawing time than 
Life4oC tissues to get good quality specular images 2.5 hours vs. 2 hours. 
Though the thawing time was longer, the image quality was significantly 
better in the Optisol-GS group. 
Price et al recently published a clinical study comparing the outcomes 
of DSAEK and DMEK with tissues stored in Optisol-GS with Life4oC(19). 
32 age matched recipients with Fuchs dystrophy were enrolled in each 
group. Baseline specular microscopy data was compared to post-op data and 
slit-lamp examination was done. At 6 months follow up all recipient corneas 
were clear. There was no significant difference between the endothelial cell 
loss of central cornea (18 ± 18% in Life4oC vs. 20 ± 20% in Optisol-GS 
group, p=0.55), the endothelial cell density and central corneal thickness 
was also comparable between the two groups 
Spence and Peyman described the technique of double staining of the 
corneal endothelium to assess the viability in the article A new technique for 
the vital staining of the corneal endothelium(37). This involved staining 
with 0.25% trypan blue followed by 0.2% Alizarin red-s. This was an 
improvement over the existing method of staining with trypan blue alone 
which stained the cells with damaged membrane alone. With the dual stain, 
the normal cells were seen as clear hexagons with the intercellular borders 
stained with alizarin, the permeable cells had their nuclei stained with 
trypan blue and areas of bare Descemet’s membrane was seen as diffuse red 
staining. This method allowed visualization of normal and abnormal cells. 
Taylor and Hunt in their article on vital staining further refined this 
method(39). They also showed the importance of maintaining the pH 
between 4.1 to 4.3 for ideal dye-lake reaction and better staining outcomes. 
 
 
 
 
 
2.1: AIMS AND OBJECTIVES 
 
The aim of this study was to determine if Cornisol is comparable to 
Optisol-GS for storing donor corneal tissues over a period of 14 days. 
The objective was to compare paired human corneas stored in 
Cornisol and Optisol-GS for 14 days and look at the endothelial cell loss 
(ECL) and also the endothelial cell vitality (ECV) histologically. 
2.1.1: PRIMARY OUTCOME MEASURE: 
The primary outcome measure of this study was endothelial cell loss 
(ECL) of donor tissue measured as percentage of baseline which were stored 
for 14 days at 2-8oC. Coefficient of Variance (CV) and percentage 
hexagonality (6A) was also documented and compared between the groups. 
2.1.2: SECONDARY OUTCOME MEASURE: 
The secondary outcome measure was to look at endothelial cell 
viability at the end of 14 days by histopathological staining and to quantify 
it by analysing photos from the microscope camera with a special software. 
 
 
 
2.2: MATERIALS AND METHODS 
Human cornea were used for the study from cadaveric donors. Only 
tissues which were considered not suitable for surgery were taken for the 
study. Tissues were obtained from Rotary Aravind Eye Bank, Madurai, 
Aravind IOB Eye Bank, Coimbatore and Prova Eye Bank, Barrackpore. 
The storage media was obtained from the respective manufacturers. 
Cornisol was supplied by Aurolab (Madurai, India) for the study and 
Optisol-GS was obtained from Bausch and Lomb (Rochester, USA) via 
Sight Life, India. 
2.2.1: Study Design: 
This is a prospective and in-vitro study conducted at a single centre.  
The study was two-armed wherein both Cornisol and Optisol-GS were 
studied in parallel using paired samples. For each pair randomization 
was done to determine which side when in which media. The observers 
were masked. 
Since the paired samples were studied simultaneously under similar 
conditions, the Optisol-GS tissue served as the control for that paired tissue 
in Cornisol. 
 
2.2.2: Sample size: 
Sample size calculation was done based on the primary outcome of 
endothelial cell loss in a parallel study. Since there are no prior studies, a 
15% difference between the two media was assumed based on clinical 
experience from various institutes and in-house studies from the 
manufacturer. Calculations were done using 80% power and 0.05 level of 
significance. The sample size required was found to be 32 donor pairs (64 
total). 
2.2.3: Inclusion Criteria: 
1. Tissues which are not suitable for surgery 
2. Paired tissues of similar optical clarity 
3. Medical reasons for not using the tissue like: 
a. Sepsis 
b. Malignancy 
c. Serology positive for HIV, HBV, HCV and Syphilis 
d. Inadequate or no blood sample  
4. Very old donors 
5. Pseudophakic donors 
6. Specular picture available at baseline examination. 
 
2.2.4: Exclusion Criteria: 
1. Gross Descemet’s membrane folds 
2. Excessive damage to the endothelium 
3. Scars interfering with specular view 
4. One eyed 
5. Gross difference between the right and left eye 
2.2.5: Tissue Collection and Transport: 
Tissues were collected from voluntary donors or through Hospital 
Cornea Retrieval Program (HCRP) by doctors and trained technicians.  
Donor demographics were documented. Time and cause of death; medical 
and ocular surgical history were also noted. 
Some tissues were collected as whole globe enucleation and stored 
temporarily in moist chamber and later transferred to the liquid storage 
media after the corneal button was prepared. While other tissues were 
collected as in situ corneoscleral buttons and stored in the media 
immediately after collection. Tissues which were transported were kept in 
ice-lined thermocol boxes to maintain temperature at 2-8oC. Adequate steps 
were taken to ensure that the cold chain is maintained throughout the 
process. 
5ml donor blood was collected from the carotid or subclavian vessels 
for serology. 
All methodology was performed as the per the eye bank protocol and 
was done by trained technicians of similar working experience. 
2.2.6: Serology: 
At the eye bank, serology was done to screen out unsuitable tissues. 
All samples were tested for the following: 
a. HIV 1 and 2 – using a tridot kit (HIV Tri-Dot test, Diagnostic 
Enterprises, Parwanoo, India) 
b. HBV – using an immunochromatograohic test (SD BioLine 
HBsAg, SD Bio Standard Diagnostics, Gurgaon, India) 
c. HCV – using an immunochromatographic test (SD BioLine HCV, 
SD Bio Standard Diagnostics, Gurgaon, India) 
d. VDRL – Treponema Hemagglutination test (Immutrep TPHA, 
Omega Diagnostics, Scotland, UK) 
2.2.7: Whole Globe evaluation: 
1. The enucleated globes were examined at the slit lamp (Model SL-1E, 
Topcon Corp, Japan) by consultants or senior fellows at the Cornea 
Clinic. 
2. They were graded as per the eye bank evaluation proforma (see 
annexure). 
3. If at this point tissues met the inclusion criteria, they were included in the 
study after being authorised by the evaluating doctor. 
2.2.8: Corneo-Scleral Button Preparation: 
1. Corneo-scleral button was prepared from these included tissues as per 
the eye bank protocols by trained technicians with similar work 
experience. 
2. The entire process was done under a laminar flow hood under strict 
sterile environment. 
3. It was then immersed in povidone iodine 5% for 3 minutes. 
4. Then it was immersed in a solution of normal saline and amikacin (for 
injection) 
5. Finally it is rinsed with normal saline. 
6. The rim was then cut with a number 15 blade and corneal scissors 
leaving about 2-3mm scleral rim around the periphery. 
7. Once the rims were prepared, moxifloxacin (0.5%) eye drop was instilled 
and the right and left side tissues were transferred to either Cornisol or 
Optisol-GS. Both were transferred at the same time to ensure the time 
they stay in the media is same.  
8. For tissues collected by in-situ method, they were randomized and 
transferred to Optisol-GS or Cornisol immediately after collection. 
2.2.9: Tissue evaluation: 
1. The corneoscleral button was examined under slit-lamp (Model SL-1E, 
Topcon Corp, Japan) while being stored in the media vial by trained 
technicians. 
2. A vial-holder with a mirror was attached to the slit lamp. The vial was 
kept upright in the slot and the tissue examined from the bottom of the 
glass vial with the help of the mirror kept at an angle. This is a simple 
method and does not require transferring tissues to a specialized viewing 
chamber thus reducing chances of contamination. 
3. The button was examined layer by layer and graded according to the 
tissue evaluation form (see annexure). 
2.2.10: Specular Microscopy: 
1. Specular microscopy was done using the Konan Eye Bank specular 
(Keratoanalyzer EKA-98, Konan Medicals, Japan) by the technicians in 
a masked fashion. Only which eye and tissue id was mentioned  
2. Each tissue was thawed for 45 to 60 minutes and brought to room 
temperature before imaging. The endothelium was focussed and area 
with the clearest view taken for analysis. 
3. The center method was used to mark individual endothelial cells. A 
minimum of 100 cells were counted to ensure that the analysis is 
accurate and representative of the whole cornea. The morphometric 
analysis was then performed by the in-built software. Data of endothelial 
cell density, co-efficient of variance and percentage hexagonality was 
taken. In images where it was not possible to count a 100 cells, at least 
50 cells were counted to have a fair accuracy(43). 
4. After taking the specular picture, the storage vials were replaced in the 
fridge and maintained at 2-8oC. 
5. A total of five specular readings were taken for each tissue on day 1, 3, 7, 
10 and 14. Each time tissue was thawed adequately before imaging and 
were replaced in the fridge after.  
6. Each pair of tissue was always handled together. This was done to ensure 
that they are exposed to similar conditions for the same amount of time. 
According to published reports, there has been no observed adverse 
effects of cooling warming and re-cooling donor corneas multiple times 
even when done daily over seven days(44). 
7. In case it was not possible to focus the endothelium clearly due to tissue 
oedema or turbid media, the particular reading was skipped. But the 
tissue was not excluded or dropped out of the study. Observation 
protocol was maintained till the 14th day. 
8. All specular readings were taken by one of three trained eye bank 
technicians with similar working experience. As per the eye bank reports, 
there was very minimal inter and intra-observer differences in specular 
microscopy evaluation. 
9. If it was not possible to take the specular picture on a specific day due to 
Sunday or other holidays, it was taken on the previous day. 
2.2.11: Histology: 
Histology was performed on the 14th day of storage after the fifth specular 
count. The thawed tissues were taken to the pathology lab and processed by 
the lab technician. Microscopy was done by the institute pathologist and the 
investigator. All was done in a masked way. 
Making the solutions: 
1. 0.2% Alizarin Red-S solution was made by mixing 0.2gm of Alizarin 
Red-S powder (SD Fine Chemicals, Chennai, India) in 70 ml 0.9% saline 
and 30 ml of 0.1% ammonium hydroxide. The final pH was between 4 
and 5 (measured approximately with pH strips). 
2. 0.25% Trypan Blue solution was made by mixing 0.25gm of Trypan 
Blue powder (HiMedia, Mumbai, India) in 100ml 0.9% saline. 
3. During the period of the study, solutions were made three times at two 
month intervals. 
Staining procedure: 
1. The corneal tissues were transferred from the storage media vial to a 
Teflon corneal cup. 
2. Trypan Blue 0.25% was added drop by drop till it covered the 
endothelium completely. It was allowed to stand for 90 seconds. 
3. The tissue was then rinsed twice with normal saline to wash off the stain. 
4. Alizarin Red-S 0.2% was added drop by drop in a similar way to cover 
the endothelial surface and allowed to stand for 90 seconds. 
5. Once again the tissue was rinsed twice with normal saline. 
6. Using a corneal trephine of 7.5mm diameter, a corneal button was 
punched from the center of the tissue. 
7. The button was lifted gently with forceps and placed on a glass slide. A 
drop of saline was put on the top and then fitted with a cover slip. 
Microscopy: 
1. The stained tissues were observed using a Leica clinical microscope 
(Leica DM-LS2, Leica Microsystems, Germany). 
2. Tissues were examined under 100x magnification to get an overall view 
and then at 200x to see the details of the endothelium clearly. 
3. Uniformity of staining pattern, areas of endothelial damage, Descemet’s 
baring and cell dropouts were noted. Polymegathism and pleomorphism 
was also noted by not quantified. 
4. Histological pictures were taking using the mounted camera (Leica DFC-
400) and using Leica Application Suite software (LAS version 4.2, Leica 
Microsystems, Germany). 
Image analysis: 
1. The images were analysed using ImageJ software (version 1.49v, Wayne 
Rasband, NIH, USA) which is an open-source program developed by the 
National Institute of Health as a versatile biomedical analysis tool(45). It 
has been used in many studies and is a validated program. 
2. Cells were counted using this program using a method similar to variable 
frame analysis. 
3. The image photographed with 200x was used for evaluation and the 
central area with sharpest focus was analysed. 
4. Between 140 to 150 contiguous intact cells were counted per image(46). 
The marked cells were then outlined to delineate the variable frame. 
After calibrating the software to the microscope magnification settings, 
the surface area of the outlined was calculated by the program. 
5. Endothelial cell density was counted by dividing the cells counted by the 
area in square millimetres (ECD = Cells (140-150)/ area in mm2). 
6. Additionally, abnormally stained cells and areas of bare Descemet’s in 
the variable frame were also noted. 
2.2.12: Data Collection: 
Data collection was divided in to four parts and tabulated in a Microsoft 
Excel spreadsheet. 
1. Donor profile: Data collected from eye bank donor sheet 
a. Age 
b. Gender 
c. Cause of death 
d. Death to preservation time – This was calculated as death to 
enucleation time plus the time kept in moist chamber for whole 
globe enucleation 
e. Reason why the tissue was not suitable for surgery. 
2. Slit lamp evaluation: Baseline data collected from the eye bank 
evaluation forms. 
a. Epithelium – graded as:  
i. Clear and intact 
ii. Mild epithelial defect 
iii. Moderate epithelial defect. 
b. Stroma – graded as: 
i. Clear and compact 
ii. Mild stromal oedema 
iii. Moderate stroma oedema 
c. Descemet’s membrane – graded as: 
i. No folds 
ii. Few folds 
iii. Moderate folds 
d. Endothelium - graded as:  
i. No stress lines, guttae or drop out areas 
ii. Few stress lines, guttae or drop out areas 
iii. Moderate stress lines, guttae or drop out areas 
e. Lens status: 
i. Phakic 
ii. Pseudophakic 
iii. Aphakic 
3. Specular microscopy: Collected from the printed specular microscopy 
images. Five sets of data collected per tissue on day 1, 3, 7, 10 and 14. 
a. Endothelial cell density 
b. Coefficient of variance 
c. Percentage hexagonality 
4. Microscopy: Data collected from analysis of histology pictures with 
ImageJ software. 
a. Number of cells counted 
b. Area of the counted cells 
c. Endothelial cell density 
d. Abnormally stained cells 
e. Areas of Descemet’s membrane baring 
2.2.13: Statistics: 
Statistical analysis was performed using Microsoft Excel (Microsoft 
Office Professional Plus 2013, Washington, USA) and using Stata statistical 
software (version 13, StataCorp, Texas, USA). 
Percentages were calculated and represented as tables and graphs. Chi 
square test was done to compare categorical data. For inter-group analysis 
two-tailed student t-test was done. Pearson coefficient of correlation was 
calculated between specular and histology data. P-value of <0.05 was 
considered statistically significant. For analysing the specular microscopy 
data at various days, the sample size was changed to the total number of 
clear images for that day and group.  
 
 
2.3: RESULTS 
The study period was from February 2015 to August 2015. Over the 
period of seven months 26 pairs of tissues were included in the study.  
One pair of tissue (sample 4) showed turbidity of the media on day 5 
and 6 for the left and right eye respectively. Subsequently specular 
microscopy was not possible. The tissue was observed till day 14 and 
histology done. Staining showed grossly damaged endothelium and large 
areas of Descemet’s baring. No specific staining patterns could be made out. 
This sample was excluded from the study. The reason for the turbidity and 
the tissue getting spoilt was probably due to microbial contamination. 
Finally the data and results were compiled using 25 pairs of tissues. 
The results will be discussed under the following headings – donor profile, 
slit lamp findings, specular data and histological analysis. 
2.3.1: Donor profile: 
Of the 25 samples included in the study, 13 (52%) were collected as 
in-situ corneoscleral buttons and remaining 12 (48%) were collected as 
whole globe enucleation. 
 
 
    
Figure 2.1 and 2.2: Pie charts showing the Tissue collection 
method and donor gender distribution. 
 
Among the donors, 16 (64%) were male and 9 (36%) were female. 
The mean donor age was 64.8 ± 18.9 years (range 35 to 95 years). When 
grouped according to age 5 (20%) were ≤50 years, 11 (44%) were between 
51 to 70 years, 8 (32%) were between 71 to 90 years and one donor (4%) 
was above 90 years of age. The following table shows a more detailed 
distribution of the age and gender distribution. 
Age 
(years) 
≤50 51-60 61-70 71-80 81-90 >90 Mean 
Age 
SD 
Male 3 1 5 3 4 0 60.7 20.7 
Female 2 2 3 1 0 1 67.2 18.1 
Total 5 3 8 4 4 1 64.8 18.9 
Table 2.1 Age and gender distribution of the donors. 
The cause of death for the donors were natural deaths in 5 (20%), 
septicaemia in 9 (36%), malignancy in 5 (20%), cerebrovascular accident in 
3 (12%), cardio-respiratory arrest in 2 (8%) and renal failure in 1 (4%). 
 
Fig 2.3: Distribution of causes of death 
The reasons for considering these tissues unsuitable for 
transplantation were sepsis in 12 (48%) donors, history of malignancy in 6 
(24%) donors, found to be seropositive in 2 (8%) cases (1 for HBV and the 
other for HIV) and 5 (20%) pairs were deemed unsuitable because of 
anatomical reasons like dense arcus senilis, old donors with pseudophakic 
eyes. 
 Figure 2.4: Pie chart showing why tissues were not used for surgery 
The mean death to preservation time was found to be 393 ± 252 
minutes (range 115 to 870). Because of the paired nature of the study, there 
was no difference in death to preservation time and storage time between 
the groups. Looking at the in-situ collection group separately, the death to 
preservation time was 222 ± 59 minutes. In the whole globe collection 
group, the death to enucleation time was similar at 189 ± 64 minutes. But 
due to long storage duration in moist chamber of 390 ± 233 minutes, the 
combined death to preservation was prolonged to 579 ± 250 minutes. 
Whole globe collection: 579 ± 250 mins 
 Death to enucleation 189 ± 64 mins 
 Moist chamber storage 390 ± 233 mins 
In situ collection: 222 ± 59 mins 
Total mean: 393 ± 252 mins 
 
Table 2.2: Table showing Death to Preservation time for tissues 
After the tissues were included in the study, the decision to put which 
eye in which media was randomly picked based on a random number 
generator (www.random.org). If even the right eye tissue was stored in 
Optisol-GS and if odd it was stored in Cornisol. 15 (60%) right eye tissues 
and 10 (40%) left eye tissues were stored in Optisol-GS and their mate 
tissues were simultaneously kept in Cornisol. 
2.3.2: Slit lamp findings: 
Epithelium examination showed a clear and intact epithelium in 9 
(36%) in the Cornisol group and 8 (32%) tissues in the Optisol-GS group, 
mild epithelial defect in 12 (48%) tissues in both groups and moderate 
epithelial defect in 4 (16%) tissues and 5 (20%) tissues in the Cornisol and 
Optisol-GS group respectively (p value = 0.919). 
The findings of the stroma showed equal distribution of grades of 
clarity in the two groups. 19 tissues (76%) were clear and compact, 5 (20%) 
showed mild stromal oedema and 1 (4%) in each group showed moderate 
stromal oedema (p-value = 1). 
No Descemet’s folds were seen in 8 (32%) tissues in the Cornisol 
group and 7 (28%) tissues in the Optisol-GS. 14 (56%) of the Cornisol 
stored tissues and 16 (64%) of the Optisol-GS stored tissues had few 
Descemet’s folds. Moderate number of folds were seen in 3 (12%) tissues in 
the Cornisol group and 2 (8%) tissues in Optisol-GS group (p-value = 
0.819) 
Endothelial findings showed a clear endothelium in 6 (24%) tissues 
stored in Cornisol versus 7 (28%) tissues stored in Optisol-GS. There was 
mild drop-outs and endothelial stress lines in 19 (76%) tissue of the 
Cornisol group and in 18 (72%) of the Optisol-GS stored tissues (p=0.747). 
The lens status showed 1 (4%) aphakic, 15 (60%) phakic and 9 (36%) 
pseudophakic tissues in the Cornisol group. Whereas the Optisol-GS group 
had 1 (4%) aphakic, 16 (64%) phakic and 8 (32%) pseudophakic tissues (p-
value = 0.955) 
There was no significant difference between the various corneal 
structures as seen on slit-lamp between the two groups. 
  
Structure Cornisol group      
n (%) 
Optisol-GS 
group    n (%) 
p-value 
Chi sq. test 
Epithelium    
     Clear and intact 9 (36%) 8 (32%)  
     Mild ED 12 (48%) 12 (48%) Chi.sq – 0.17 
     Moderate ED 4 (16%) 5 (20%) p = 0.919 
Stroma    
     Clear and compact 19 (76%) 19 (76%)  
     Mild oedema 5 (20%) 5 (20%) Chi.sq = 0 
     Moderate oedema 1 (4%) 1 (4%) P = 1 
Descemet’s membrane    
     No folds 8 (32%) 7 (28%)  
     Few folds 14 (56%) 16 (64%) Chi.sq = 0.4 
     Moderate folds 3 (12%) 2 (8%) P= 0.819 
Endothelium    
     Clear 6 (24%) 7 (28%) Chi.sq = 0.104 
     Mild dropouts 19 (76%) 18 (72%) P = 0.747 
Lens status    
     Aphakic 1 (4%) 1 (4%)  
     Phakic 15 (60%) 16 (64%) Chi.sq = 0.091 
     Pseudophakic 9 (36%) 8 (32%) P = 0.955 
 
Table 2.3: Slit Lamp Findings (total n=25 in each group) 
 
 
2.3.3: Specular microscopy findings: 
In the Cornisol group we were able to obtain clear specular images 
were obtained for all 25 tissues on day 1 and 3, 24 tissues on day 7, 20 
(80%) on day 10 and 14 (56%) tissues on day 14. Where as in the Optisol-
GS group good specular pictures were taken for all 25 tissues on day 1 and 3, 
24 (96%) tissues on day 7, 21 (84%) tissues on day 10 and 15 (60%) tissues 
on day 14. This served as the sample size for calculations on those particular 
days. 
For few tissues the subsequent specular reading was not possible on 
the specified date if it fell on a Sunday or hospital holiday. In those cases, 
the reading was taken on the day before (e.g. day 6 instead of day 7). 
As expected, the endothelial cell count showed a decrease in count 
with each serial imaging. In the Cornisol group the ECD decreased from 
2667 ± 334 (range 2016 to 3311; n=25) on day 1 to 2308 ± 329 cells/mm2 
(range 1824 to 2967; n=14) on day 14, whereas in the Optisol-GS this 
parameter changed from a baseline count of 2828 ± 270 (range 2309 to 
3472; n=25) on day 1 to 2431 ± 415 cells/mm2 (range 1558 to 2881; n=15) 
on day 14. The following table gives the ECD counts for each observed day 
and the corresponding t-test result. 
 
 Cornisol 
(mean ± SD) 
Optisol-GS 
(mean ± SD) 
p-value 
Baseline (day 1) 2828 ± 270 
(n=25) 
2667 ± 334 
(n=25) 
0.076 
(n=25) 
Day 3 2609 ± 335 
(n=25) 
2602 ± 319 
(n=25) 
0.917 
(n=25) 
Day 7 2580 ± 329 
(n=24) 
2444 ± 337 
(n=24) 
0.183 
(n=23) 
Day 10 2499 ± 303 
(n=21) 
2370 ± 418 
(n=20) 
0.053 
(n=20) 
Day 14 2431 ± 415 
(n=15) 
2308 ± 329 
(n=14) 
0.192 
(n=12) 
 
Table 2.4: Mean (±SD) ECD at various days in the two groups 
For some tissues, SPM image was available for only one eye on 
certain days. Because a paired two-tailed t-test was done to test the level of 
significance, the number of samples used to calculate was less than the total 
images. As seen from the above table, the p-values were not significant and 
only on day 10 it was close to 0.05. 
 Figure 2.5: Bar graph showing the ECD (±SD) at various days 
The endothelial cell loss, represented as a percentage of the baseline 
count, was 13.46% in the Cornisol group compared to a 14.04% decrease in 
the Optisol-GS stored tissues (p value = 0.2533). 
 
 
 
 
 
 Cornisol 
Mean ECD 
ECL (as % 
of baseline) 
Optisol-GS 
Mean ECD 
ECL (as % 
of baseline) 
Baseline (day 1) 2828 - 2667 
 
- 
Day 3 2609 2.44 2602 
 
7.74 
Day 7 2580 
 
8.36 2444 
 
8.77 
Day 10 2499 
 
11.14 2370 
 
11.63 
Day 14 2431 
 
13.46 2308 
 
14.04 
 
Table 2.5: Percentage endothelial cell loss over 14 days in the two 
groups 
 
 
Figure 2.6: Percentage ECL shown as line graph comparing the two 
media 
 
 
As denoted by the line graph over time, except the difference on the 
first day, the endothelial cell loss occurs at similar rates in both the groups. 
The coefficient of variance showed an upward trend for till day 7 and then 
stabilized over the next 7 days in both the groups. In the Cornisol group, the 
values moved from 41.1 ± 6.5 on day 1 to 44.3 ± 5.9 on day 7 and was 44.6 
± 10.7 on day 14. In Optisol-GS group it increased from 41.3 ± 5.1 to 44.7 ± 
5.8 on day 7 and was 43.6 ± 5.5 on day 14. As seen in the following table 
for each day there was no significant difference between the two groups. 
 Cornisol (n) Optisol-GS (n) p-value 
Baseline (day 1) 41.1 ± 6.5 
(n=25) 
41.3 ± 5.1 
(n=25) 
0.876 
(n=25) 
Day 3 44.5 ± 8.1 
(n=25) 
44.4 ± 5.6 
(n=25) 
0.961 
(n=25) 
Day 7 44.3 ± 5.9 
(n=24) 
44.7 ± 5.8 
(n=24) 
0.934 
(n=23) 
Day 10 45.7 ± 10.0 
(n=21) 
44.1 ± 4.9 
(n=20) 
0.485 
(n=20) 
Day 14 44.6 ± 10.7 
(n=15) 
43.6 ± 5.5 
(n=24) 
0.723 
(n=12) 
 
Table 2.6: Mean CV (±SD) over 14 days in the two groups 
 
The hexagonality is inversely related to the CV and therefore, 
predictably, showed a declining trend in both the groups. In the Cornisol 
group it started as 51.2 ± 7.5% at baseline and fell to 44.6 ± 8.9%. 
Compared to that in the Optisol-GS group the baseline was 52.6 ± 6.1% and 
on day 14 it had decreased to 46.0 ± 4.7%. There was no significant 
difference between the two groups on any of the 5 days (see table for p-
values). 
 Cornisol (n) Optisol-GS (n) p-value 
Baseline (day 1) 51.2 ± 7.5 
(n=25) 
52.6 ± 6.1 
(n=25) 
0.301 
(n=25) 
Day 3 47.1 ± 1.1 
(n=25) 
48.4 ± 4.4 
(n=25) 
0.415 
(n=25) 
Day 7 47.2 ± 5.2 
(n=24) 
46.8 ± 4.6 
(n=24) 
0.627 
(n=23) 
Day 10 45.6 ± 6.4 
(n=21) 
45.4 ± 7.6 
(n=20) 
0.885 
(n=20) 
Day 14 44.6 ± 8.9 
(n=15) 
46.0 ± 4.7 
(n=24) 
0.626 
(n=12) 
 
Table 2.7: Mean (± SD) Percentage Hexagonality in the two groups 
 
 
Figure 2.7: Changes in percentage hexagonality shown as a line graph 
2.3.4: Histology Findings: 
Histology showed adequately stained endothelium in 24 (96%) of 
tissues in Cornisol group and 23 (92%) of the Optisol-GS tissues. Of the 
three tissues which did not take up stain properly, two had specular images 
on the last day and one did not. And two of these tissues were from 
pseudophakic donors. 
Out of the 47 histology slides which were analysed, 42 (89.4%) had 
an intact endothelial layer. In 5 tissues (3 Cornisol group, 2 Optisol-GS 
group) there were lots of Descemet’s folds seen as linear areas of Alizarin 
staining suggesting loss of endothelial cells. In most slides few areas 
isolated drop outs were seen usually located peripherally. Most slides also 
showed areas of junctional separations. These appear as small alizarin 
stained areas in the intercellular area where Descemet’s membrane is 
exposed due to separation of the adjacent endothelial cells. Probably this is 
due to cell shrinkage or pleomorphism (39).  
Abnormally stained isolated cells were also seen in most slides, but in 
5 tissues (2 Cornisol stored, 3 Optisol-GS stored) there were large confluent 
areas of abnormal cells. This might suggest some focal endothelial stress. 
Pleomorphism and polymegathism was not quantified, but as a general 
observation, it was more predominant in pseudophakic tissues and in old 
donors. 
In the Cornisol group 23 tissues were analysed. An average of 145 
cells were counted (± 1.3; range 142 to 147) in each slide. The average area 
occupied by the cells was found to be 61757 ± 8360 sq. micron. Mean 
number of abnormally stained cells seen was 0.8 (range 0 to 3) and number 
of drop out areas was 1.0 (range 0 to 7). The mean endothelial cell density 
was found to be 2380 ± 287 cells/mm2 (range 1729 to 2776). 
In the Optisol-GS group 24 tissues were analysed. An average of 145 
cells were counted (± 1.5; range 142 to 147). The average area of the 
counted cells was found to be 61260 ± 15815 sq. micron. The average 
number of abnormally stained cells was 1.0 (range 0 to 4) and the number of 
drop out areas was 1.8 (range 0 to 8). The mean endothelial cell density was 
found to be 2330 ± 309 cells/mm2 (range 1800 to 2781).  
In one of the slides in this group, it was not possible to count all the 
cells as a single contiguous areas due to poor focus and some abnormal cells. 
In that particular slide, two areas of contiguous cells were counted get the 
complete number. This is as per the protocol described in the SMAS 
study(43). 
Two-tailed paired t-test was calculated between the groups for 22 
paired values of endothelial cell density and p value was found to be 0.28. 
Additionally intra-group Pearson co-efficient was calculated between the 
ECD at baseline and the value obtained by histology analysis. It was found 
to be 0.49 in the Cornisol group (n=23) and 0.34 in the Optisol-GS group 
(n=24). Both are positive values and signifies a positive correlation between 
the SPM count and the histological count.  
 Cornisol (n=23) Optisol-GS (n=24) 
Cells counted 145 ± 1.3 145 ± 1.5 
Area of cells (sq. micron) 61757 ± 8360 61260 ± 15815 
Abnormal staining 0.8 1.0 
Drop out areas 1.0 1.8 
ECD (cells/sq.mm) 2380 ± 287 2330 ± 309 
Pearson coefficient 0.49 0.34 
 
Table 2.8: Comparison of the histological analysis with ImageJ 
 
 
 
 
 
 
 
 
2.4: DISCUSSSION 
Cornisol is an indigenous intermediate term hypothermic corneal 
storage medium which is approved for storing tissues for up to 14 days at 2-
8oC(47). It is a chondroitin sulphate containing media which combines the 
constituents of Optisol-GS and Life4oC. So far there are no published 
studies comparing Cornisol with other intermediate medium. The data 
available on the product page(47) is the result of a multi-center trial done 
before the launch of the product. 
Component  Optisol-GS# Life4oC# Cornisol* 
Base Medium MEM Yes Yes Yes 
Glycosaminoglycans CDS Yes Yes Yes 
Buffers HEPES,  
Sodium 
bicarbonate 
Yes Yes Yes 
Deturgescent agent Dextran-40 Yes Yes Yes 
Antibiotics Gentamicin, 
Streptomycin 
Yes Yes Yes 
Human recombinant insulin No Yes Yes 
Glutathione  No Yes No 
Amino acids  Yes Yes Yes 
ATP precursors  Yes Yes Yes 
L-glutamine  No Yes Yes 
Vitamins, co-enzymes No Yes Yes 
Trace elements  No Yes Yes 
Additional 
supplements  
(anti-oxidants, 
membrane 
stabilizers etc.) 
No Yes No 
Table 2.9: Comparison of the components of Optisol-GS, Life4oC and 
Cornisol. [#Optisol-GS and Life4oC data from Pham et al (25) *Cornisol 
data from Aurolab website (47)] 
This study was designed as a paired comparative design and not as an 
equivalence or superiority trial. Though the results would be more relevant, 
we would need many more samples to carry out such a trial. It is probably 
for the same reason that all the comparative studies done none of the 
investigators have used a superiority or equivalence design. 
Our sample size in each arm was similar to the study done by Price et 
al(19) (34 vs. 32). The difference can be attributed to the changes in certain 
assumptions that we made. We were not able to include the target number of 
samples (25 vs. 34 planned). But in spite of that 25 paired sample is 
comparable to the previously done in vitro studies. The initial in vitro 
studies comparing Optisol and DexSol Kaufman et al used 15 pairs(14), 
Lindstrom used 26 pairs(13), Nelson et al used  pairs to compare Chen 
media vs. Optisol-GS(17), Pham et al (25) studied Life4oC and Optisol-GS 
using 25 pairs.  
Since we used paired samples, the donor profile, the death to 
preservation time, and the time spent in storage was equal in each group. 
Which means that for each pair, the Optisol-GS stored tissue was an ideally 
matched standard control. This eliminated any selection bias. 
The slit-lamp findings in both the groups were similar in both the 
groups. Except one donor, aphakia and pseudophakia was present bilaterally. 
So differences in cornea due to surgical intervention was also equally 
distributed in 24 (96%) of the sample pairs. 
The specular parameters showed no significant difference between 
the Cornisol stored and Optisol-GS stored tissues. This finding was true at 
baseline and at the four subsequent days. This data comparable to the results 
obtained by Pham et al in vitro(25) and Price et al in vivo(19) studies to 
compare Life4oC and Optisol-GS.  
The observed endothelial cell loss percentage was 13.46% in Cornisol 
and 14.04% in the Optisol-GS group. This is little more than the 5±5% 
reported by Nelson et al for Optisol-GS. Our findings were consistent with 
Parekh et al(20) where they reported a 8.03±6.6% (vs. 8.77% in our study) 
at 1 week and further drop of 8.01±6.5% (vs. 5.27% in our study) at end of 
second week The findings in the Cornisol group was 8.36% and another 
5.10% at the end of first and second week respectively. Though not 
statistically significant, the endothelial cell loss was found to be less in the 
Cornisol group (especially on day 3 – 2.24% vs. 7.74%). This could be 
attributed to the addition of components like recombinant human insulin 
which enhances nutrient uptake by the cells, presence of L-glutamine, 
vitamins and co-enzymes which help in enhancing the cell metabolism and 
has some anti-oxidant property. 
The changes noted in CV and 6A in both the groups were comparable 
to results noted by Kanavi et al in comparing Optisol-GS and Eusol-C (CV 
39 ± 9 vs. 44 ± 6 that we noted at 1 week and 6A of 50 ± 12 vs. 47 ± 5 in 
this study). Our findings were also consistent with the study between Chen 
medium and Optisol-GS by Nelson et al(17) where they noted decreasing 
hexagonality and increasing co-efficient of variance. 
We also noticed that it was not possible to take clear specular 
microscopy pictures from day 7 onwards and we could get good SPM 
images for 21 and 15 tissues in Optisol-GS group and for 20 and 14 tissues 
in the Cornisol group on day 10 and 14 respectively. This could probably be 
due to some tissue oedema which caused light scattering and loss of 
transparency. Lindstrom et al noted decreasing number of cells per field of 
specular image in their extensive study(13). Parekh et al, in their study 
comparing Optisol-GS with a new storage developmental medium called 
Cornea Cold(20), noticed similar loss of transparency in tissues stored in 
either medium (5.6% vs. 11.73% loss of transparency at first and second 
week for Optisol-GS stored tissues). They also noted a downward trend in 
the overall morphology of the endothelial cells. This however should not be 
a cause for concern because most tissues are expected to be utilized before 7 
days. 
The histological examination revealed a completely intact 
endothelium in 89.4% of the tissues. This is comparable to the histological 
studies done by Parekh et al(20) and the electron microscopy studies done 
by Kaufman et al(14) and Nelson et al(17). Increased polymorphism and 
pleomorphism were noted but not quantified.  
Quantification of endothelial cell density using ImageJ has not been 
done before for such comparison studies. We used the methodology 
followed in the Specular Microscopy Ancillary Study subgroup of the 
Corneal Donor Study(43). ImageJ is an image analysis software developed 
by the National Institute of Health, USA for biomedical purposes. It has 
been validated for many studies. There are two published studies where this 
program was used to analyse the endothelium. Bernard et al used it to 
quantify area of viable endothelium (48) and Jardine et al used the software 
to calculate the endothelial cell density and compared it with using Adobe 
Photoshop(49). We found no significant difference in the ECD in the tissues 
stored in either group. Also there was a positive correlation between the 
baseline count and the histological count in each group (Pearson coefficient 
of 0.49 and 0.34 in Cornisol and Optisol-GS respectively). 
In some of the slides, we noticed small round, transparent, refractile 
bodies, sometimes singly and sometimes in clumps. These were present on 
the endothelial surface. Slit lamp examination of the media vials did not 
reveal any particulate matter. They bear resemblance with starch powder 
seen under microscope(50) which is a possible contaminant from the 
powder gloves(51). We are not sure about the clinical significance of glove 
powder on the endothelium but it can cause TASS in some patients. 
The strength of the study lies in its paired design which ensures that 
each pair goes through the same methodology. This eliminates selection bias. 
The randomization and masked nature helps to reduce observation bias. 
Usable tissues were wasted in this study. The tissues were not suitable for 
surgery because of medical reasons but otherwise they were of optical grade 
with good endothelial counts at baseline. Therefore we got a practical 
picture because usually the intermediate media are used to store and 
transport optical grade tissues in our country. 
As with most studies there are certain drawbacks in this one. This was 
an entirely in vitro study. So we can only predict that the results will hold in 
a clinical setting. We did not measure the thickness of the corneal tissue. 
When Optisol was introduced in early 90s, one of the main advantage over 
DexSol (the most popular intermediate storage then) was that tissues stored 
were significantly thinner both during storage and in-operative period. We 
can expect that because both Optisol-GS and Cornisol have the same 2.5%2 
Chondroitin sulphate and 1% dextran as the main constituents, the thickness 
of the stored tissues will be similar. But it would be better to measure it 
objectively and compare statistically. Going by the experience of the corneal 
surgeons using this media, the consensus is that both Cornisol and Optisol-
GS stored tissues are much thinner than tissues stored in MK Medium. 
We also did not evaluate if the addition of components like human 
recombinant insulin, L-glutamine and vitamins actually has any bearing on 
the storage quality. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.5 CONCLUSION 
For all practical purposes, Cornisol seems to be an equivalent and 
cost-effective substitute for intermediate term storage in Indian and 
developing country perspective. 
Histological analysis and correlation is a very powerful way to 
support the specular findings. With dual staining it is possible to identify 
cells with abnormal cell membrane which might appear normal on SPM 
image. Whereas previous studies only commented on the staining pattern, 
we quantified the cell count with the ImageJ software and correlated it with 
the initial findings. This has not been done before in the storage media 
comparison studies. 
As the next step to evaluate Cornisol we suggest that a clinical trial 
could be undertaken. The parameters to look for would be the intra-storage 
and intra-operative thickness of tissue, the endothelial cell loss in the 
transplanted graft over 1 year follow-up and the best corrected visual acuity. 
Something similar to studies by Lindstrom et al(13) and Price et al(19).  
Plate 1: Short and Intermediate-Term Storage Media 
            
Moist Chamber   MK Medium 
                      
Optisol-GS         Life4oC 
 
Eusol-C 
 
 
Plate 2: Principles of specular microscopy 
                                  
        Specular reflection   Specularly reflected rays from the                           
                                                                   epithelium and endothelium  
                                                                    are captured by the device. 
 
 
How guttae reflect light and appear on specular 
 
 
Specular picture depends on the thickness of cornea and width of the 
light beam 
Plate 3: Types of Specular Microscopes 
      
Eye bank specular microscopes have a holder for the vial, x-y movable 
stage. Pachymeter and media temperature monitors are seen in high-
end models. 
 
 
Clinical specular microscopes are designed to image human subjects 
 
 
Plate 4: Methods of Specular Morphometric Analysis 
        
         a. Fixed Frame Method       b. Variable Frame Method 
 
        c. Corner Method     d. Center Method       e. Center-Flex 
Method 
   
            Clinical Specular output                          Eye bank Specular 
Output 
 
Plate 5: Histopathology 
  
 
 
a. Intact epithelial sheet. 
Alizarin stains the 
intercellular membranes 
and trypan blue 
normally does not stain 
anything.  
Note the transparent 
refractile bodies. 
b. Abnormally stained cells 
(black arrow) and cell drop 
outs (white arrows). 
Abnormal cell membranes 
allow the dyes to center and 
stains the nuclei and 
organelles blue and red. 
Drop out areas are seen as 
diffusely stained bare 
Descemet’s membrane. 
 
c. Pseudophakic tissues 
show more pleomorphism 
and polymorphism. 
Junctional areas are bare 
DM where the cells have 
separated (yellow arrow) 
 Plate 6: Methodology: Corneo-scleral button excision 
     
     Procedure done in laminar flow       Preparing the instruments 
      
       Globe is decontaminated in iodine                   CS button being excised 
                       and antibiotic 
 
 
Serology kits (HIV Tridot, HBV and HCV immunocards and TPHA)  
 
Plate 7: Slit lamp evaluation 
        
              Slit lamp attached with               The mirror arrangement 
allows 
               holder for media vials                 tissue visualization through 
                                                                          the bottom of the vial 
 
 
Trained eye bank technicians evaluate and grade the tissues 
 
 
Plate 8: Specular Microscopy 
         
Eye bank specular with holder for media vial 
 
Computer connection allows storage and retrieval of images 
 
In-built software for morphometric analysis 
 
Plate 9: Staining method of tissues 
     
                        0.2% Alizarin Red             0.25% Trypan Blue 
        
                Tissue at 14 days          Teflon block and 7.5mm Trephine 
 
Staining was done under a laminar flow hood 
 
Plate 10: Staining of Tissues contd. 
 
Trypan blue is added drop-wise and allowed to stain for 1:30 
minutes and then rinsed with saline 
 
Alizarin Red-S is added next in drops and allowed to stain for 1:30 
minutes. Tissue is then rinsed in saline. 
    
A 7.5 mm button is punched with trepine 
 
 
Tissue is mounted in saline and placed under cover slip 
Plate 11: Microscopy 
      
Tissues are examined in Leica microscope with attached camera 
 
Computer is used to capture the camera images 
 
Leica Application Suite Software 
 
Plate 12: Using ImageJ to analyse the histopathology photos 
 
a. Image is loaded 
 
b. Scale adjusted according to magnification 
 
c. For a 200x photo, 100 micron = 234 pixels (2.34pixel/µm) 
 
Plate 13: Histopathology analysis contd. 
 
d. 140-150 contiguous cells are counted 
 
e. Variable frame marked by outlining the marked cells 
 
f. Enclosed area is calculated 
 
Plate 14: Serial Specular Images of a Sample over 14 days (5 readings) 
 
          Day 1 Optisol-GS                                 Day 1 Cornisol 
 
            Day 3 Optisol-GS     Day 3 Cornisol 
 
            Day 7 Optisol-GS      Day 7 Cornisol  
 
 
 
Plate 15: Serial Specular Images of a Sample contd. 
     
Day 10 Optisol-GS                 Day 10 Cornisol  
 
       
Day 13 Optisol-GS                 Day 13 Cornisol 
 
Here we notice that in both the tissues stored in Optisol-GS and Cornisol, 
there is a steady decline in the endothelial count. Also the Co-efficient of 
variance increases over time associated with an inverse decrease in the 
percentage hexagonality. 
 
 
 
Plate 16: Histology Results 
 
    
1: Intact endothelial layer in both tissues. Left was Cornisol stored, right was 
Optisol-GS stored. Yellow border shows counted area. 
    
2: Pair of sample from bilateral pseudophakic donor. Note extensive polymorphism 
and polymegathism. The right Optisol-stored tissue was counted as two separate 
groups of cells. 
    
3: The Optisol-GS stored right eye shows staining along a Descemet’s fold. 
Otherwise both tissues show an intact mosaic. 
Plate 17: Some peculiar results 
        
Discarded sample: note the clouding and change in colour of the medium. Compare 
with normal vial on the right. 
 
Refractile bodies (singly and in groups) noted in the slides 
  
Microscopic appearance of starch and glove-powder artefact for comparison 
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ANNEXURE 1: EYE BANK FORMS 
 
1: Consent form 
 2: Donor information 
 3: Donor information (reverse side) 
 4: Whole globe evaluation form 
 5: Slit lamp evaluation of the cornea 
ANNEXURE 2: PROFORMA 
 
A prospective, in vitro, randomized study to compare an indigenous 
intermediate term corneal storage medium with Optisol-GS 
 
Sample Number: 
 
Age:    Gender: 
Death to Enucleation Time (min):  
Moist Chamber to Media Time (min): 
Cause of Death: 
Reason discarded: 
 
Slit Lamp findings: 
 RE LE 
Epithelium   
Stroma   
Descemet   
Endothelium   
Lens status   
 
RE stored in: Optisol-GS/ Cornisol 
LE stored in: Optisol-GS/ Cornisol 
 
 
 
 Specular Findings: 
RE 
Day (date) 1 3 7 10 14 
CD      
CV      
6A      
 
LE 
Day (date) 1 3 7 10 14 
CD      
CV      
6A      
 
 
Histology Findings: 
 RE LE 
Cells counted   
Area in µm2   
ECD = count/area   
Abnormal staining   
Dropout areas   
 
 
 
 
 
  
 
  
 
  
Serial Tissue ID Age Gender Cause of Death DtE EtM DtP Reason for Unsuitability
1 MDU/337 45 M Bone Cancer 75 120 195 Cancer with secondaries
2 MDU/419 95 F Natural 150 720 870 Old donor
3 MDU/446 78 M Renal failure 210 180 390 NSFS - Sepsis
4 CBE/310 90 M Natural 90 360 450 Old donor
5 MDU/447 87 M Natural 240 480 720 Old donor
6 PEB/304 85 M CVA 275 275 NSFS - Sepsis
7 CBE/329 70 F Natural 180 480 660 Old donor
8 MDU/456 90 M Cardiorespiratory arrest 210 120 330 Old donor
9 PEB/309 65 M Hepatic encephalopathy 225 225 NSFS - Sepsis
10 PEB/310 27 F Sepsis + Electrolyte Imbalance 320 320 NSFS - Sepsis
11 MDU/465 70 M Bone cancer 330 480 810 Cancer
12 PEB/324 36 M Hepatic encephalopathy 245 245 NSFS - Sepsis
13 PEB/335 30 M Sepsis + Multiorgan failure 205 205 NSFS - Sepsis
14 MDU/496 68 F Natural 130 720 850 Cancer
15 PEB/349 87 M Sepsis + Hepatic Encephalopathy 260 260 NSFS - Sepsis
16 PEB/358 62 M Pneumonia 245 245 NSFS - Sepsis
17 MDU/517 78 M CVA 165 480 645 Dense arcus
18 MDU/518 57 F Lung Cancer 240 600 840 NSFS - Cancer
19 PEB/363 35 F Sepsis + Bleeding diathesis 160 160 NSFS - Sepsis
20 PEB/370 72 F Sepsis + Multiorgan failure 115 115 NSFS - Sepsis
21 MDU/537 70 F Natural 180 150 330 Seropositive HBV
22 PEB/403 67 M Carcinoma base of tongue 175 175 NSFS - Cancer
23 MDU/583 67 M Cardiorespiratory arrest 160 150 310 NSFS - Sepsis
24 PEB/430 55 M CVA 250 250 NSFS - Seropositive HBV
25 PEB/457 52 F Sepsis + Electrolyte Imbalance 265 265 NSFS - Sepsis
26 PEB/473 73 M Cardiorespiratory arrest + Hepatocellular carcinoma 145 145 NSFS - Cancer
DtE = Death to enucleation time SLE = Slit lamp examintion
EtM = Enucleation to media time SPM = Specular Microscopy
DtP = Death to preservation time HPE = Histopathology Examination
ECD = Endothlial cell denstiy DM = Descemet's membrane
CV = Coefficient of variation OS = Optisol; CS = Cornisol
HEX = Percentage hexagonality
C&I = Clear and intact
Note: Sample 4 excluded from study
Time in minutes
Area in sq.micron
RE = Right Eye; LE = Left Eye ECD in cells/sq.mm
CVA = Cerebrovascular accident
NSFS = Not suitable for surgery
ED = Epithelial Defect
C&C = Clear and compact
Abbreviations used
M = Male; F = Female
SLE
Epithelium Stroma DM Lens status Endothelium Epithelium Stroma DM Lens status Endothelium
Mod ED Mild edema Few Phakic Mild dropout Mild ED Mild edema Mod folds Phakic Mild dropout
Mild ED C&C Mod folds Pseudophakic Mild dropout Mild ED C&C Few Pseudophakic Mild dropout
Mild ED Mod edema Few Pseudophakic Mild dropout Mild ED Mod edema Mod folds Pseudophakic Mild dropout
Mild ED Mod edema Mod folds Phakic Mod defects Mild ED Mod edema Mod folds Pseudophakic Mod defects
Mild ED Mild edema Few Aphakic Mild dropout Mild ED Mild edema Few Aphakic Mild dropout
Mod ED C&C No fold Phakic Mild dropout Mod ED C&C No folds Phakic Mild dropout
Mod ED Mild edema Few Pseudophakic Clear Mod ED Mild edema Few Pseudophakic Clear
Mild ED C&C Few Phakic Clear Mild ED C&C Mod folds Phakic Clear
Mild ED C&C Few Phakic Mild dropout Mild ED C&C Few Phakic Mild dropout
C&I C&C No fold Phakic Mild dropout C&I C&C No folds Phakic Mild dropout
Mild ED Mild edema Few Pseudophakic Clear Mild ED Mild edema Few Pseudophakic Clear
Mod ED C&C No fold Phakic Mild dropout Mod ED C&C No fold Phakic Mild dropout
Mild ED C&C Few Phakic Clear Mild ED C&C Few Phakic Clear
C&I C&C Few Pseudophakic Mild dropout C&I C&C No fold Pseudophakic Mild dropout
C&I C&C Few Phakic Mild dropout C&I C&C Few Pseudophakic Mild dropout
C&I C&C Few Phakic Mild dropout C&I C&C No folds Phakic Mild dropout
C&I C&C Few Pseudophakic Mild dropout C&I C&C Few Pseudophakic Mild dropout
C&I C&C Few Phakic Mild dropout C&I C&C Few Phakic Mild dropout
Mild ED C&C No fold Phakic Mild dropout Mild ED C&C No fold Phakic Mild dropout
Mild ED C&C No fold Phakic Clear C&I C&C No fold Phakic Clear
Mild ED C&C Few Phakic Clear Mild ED C&C Few Phakic Clear
Mod ED C&C Few Phakic Mild dropout Mod ED C&C Few Phakic Mild dropout
Mild ED C&C Few Phakic Mild dropout Mild ED C&C Few Phakic Mild dropout
C&I C&C Few Pseudophakic Clear C&I C&C Few Pseudophakic Mild dropout
C&I C&C No fold Phakic Mild dropout C&I C&C No fold Phakic Mild dropout
Mild ED Mild edema Few Pseudophakic Mild dropout Mild ED Mild edema Few Pseudophakic Mild dropout
Optisol-GS Eye Cornisol Eye
SPM OS Eye
Day 1 Day 3 Day 7 Day 10 Day 14 Day 1 Day 3 Day 7 Day 10 Day 14 Day 1 Day 3 Day 7 Day 10 Day 14
LE 2574 2113 2001 47 53 55 56 54 54
RE 2347 2018 1988 53 58 58 47 48 45
RE 2689 2584 2499 2269 2116 43 46 46 47 49 58 53 53 50 48
RE 2209 41 50
RE 2617 2202 2525 2472 42 37 46 38 46 50 45 50
LE 2309 2237 2092 1744 41 42 39 38 49 55 50 44
LE 3472 3022 2789 47 48 52 44 43 48
RE 3215 2415 2604 2173 47 42 49 43 47 52 52 50
LE 2564 2475 2331 2597 2631 45 49 45 47 52 53 50 43 51 36
LE 3115 3049 2801 2832 37 34 38 35 66 57 54 52
RE 2949 2118 2369 34 46 50 59 49 35
RE 2941 2770 2618 2717 2242 41 45 40 49 46 51 41 50 37 50
LE 2933 2740 2632 2596 2702 36 51 49 53 37 61 42 42 56 45
RE 2932 2785 2669 2375 2849 42 47 45 45 46 49 48 44 45 43
RE 2770 2558 2469 2353 2424 40 42 43 44 32 44 41 46 32 50
LE 2817 2618 2558 2457 43 49 44 47 51 44 44 37
RE 2754 2331 3067 2217 2127 34 44 37 35 44 59 46 45 45 48
RE 2941 3154 3289 2840 2695 49 47 35 38 43 54 52 51 48 54
LE 2481 2364 2232 2101 2762 44 45 42 41 45 59 48 47 48 51
LE 2967 2801 2421 1786 1558 40 46 47 42 38 51 49 47 43 49
RE 3058 3105 2976 3012 2680 32 34 52 50 52 47 50 49 41 44
RE 2681 2513 2387 2617 2881 42 43 45 47 43 54 43 38 44 45
RE 2659 3154 3115 2731 42 39 38 41 45 49 51 39
LE 3115 2653 2564 2469 39 44 41 45 51 49 38 44
RE 2907 2747 2667 2506 2208 38 39 46 47 44 52 53 41 42 44
RE 2882 2710 2625 2994 2840 35 40 41 43 45 62 45 46 65 39
ECD CV HEX
CS Eye
Day 1 Day 3 Day 7 Day 10 Day 14 Day 1 Day 3 Day 7 Day 10 Day 14 Day 1 Day 3 Day 7 Day 10 Day 14
RE 3311 2873 3460 39 47 48 55 50 46
LE 3003 2745 2326 53 54 57 43 43 40
LE 2459 2434 60 69 43 37
LE 2500 37 14
LE 2016 1996 2336 2174 37 34 47 47 36 43 44 43
RE 2519 2433 2203 1824 49 39 47 40 51 49 51 32
RE 2304 2747 2457 40 52 54 36 48 40
LE 2403 2352 2386 2176 1829 44 42 56 52 53 46 39 42 45 43
RE 2545 2336 2232 2201 49 39 48 58 54 40 45 31
RE 2882 2660 2519 2487 35 37 42 49 57 57 49 51
LE 2475 2439 2413 2663 2458 29 39 39 42 44 65 50 49 44 42
LE 2849 2639 2532 2538 2677 39 46 43 58 74 50 46 46 46 37
RE 2740 2558 2433 2487 2349 39 43 38 39 40 56 55 45 61 42
LE 2409 2724 2501 2263 2048 49 44 47 47 50 48 42 44 46 43
LE 2532 2381 2252 2020 2311 39 40 46 43 35 44 53 40 45 41
RE 3125 2915 2833 2695 40 35 45 40 57 57 45 49
LE 2202 2247 1891 1697 2267 41 37 36 34 46 52 40 50 41 40
LE 3144 2808 2921 2389 2496 39 50 36 36 33 52 47 64 47 63
RE 2404 2375 2247 2088 2085 38 40 40 51 48 50 53 53 41 44
RE 2915 2762 2268 1637 38 46 41 42 56 51 50 41
LE 2949 3355 2352 2608 2412 43 39 43 46 47 47 54 47 47 42
LE 2558 2381 2053 2205 1994 41 44 43 36 38 47 33 45 44 55
LE 2512 3134 2525 3278 39 40 37 30 54 35 54 58
RE 2415 2070 1972 1942 35 58 49 74 62 55 47 43
LE 3155 2967 2882 2778 2597 36 54 42 49 46 58 54 47 49 39
LE 2841 2740 2667 3076 2967 37 44 40 40 31 62 46 50 39 61
CV HEXECD
HPE
Eye Good Partial Dropout Area ECD Eye Good Partial Dropout Area ECD
LE 146 3 1 68288 2138 RE 144 4 1 60075 2397
RE 143 2 7 75323 1898 LE 144 1 4 61422 2344
RE 145 0 2 61038 2376 LE 147 2 1 79774 1843
RE 144 2 0 55408 2599 LE 144 0 0 68540 2101
LE 145 0 0 78767 1841 RE 144 0 0 72389 1989
LE RE 145 2 8 72825 1991
RE 144 2 0 68118 2114 LE 146 2 4 81095 1800
LE 143 1 3 59726 2394 RE 146 1 3 54696 2669
LE 146 0 0 58173 2510 RE 145 1 0 54949 2639
RE 147 0 1 52956 2776 LE 142 1 0 55739 2548
RE 146 0 0 56469 2585 LE 145 0 0 54649 2653
LE 144 0 0 52619 2661 RE 143 2 4 54875 2606
RE 146 1 2 64105 2277 LE 147 2 8 66216 2220
RE 147 1 0 61009 2409 LE 145 1 1 71107 2039
LE 145 1 1 54889 2642 RE 145 1 0 56470 2568
RE 142 0 0 65786 2159 LE
RE 145 0 0 58819 2465 LE 144 0 0 56855 2533
LE 144 0 0 62341 2310 RE 145 0 0 62312 2327
LE 145 0 2 83887 1729 RE 148 1 3 81308 1820
RE LE 145 0 0 23 2781
RE 144 2 0 57636 2498 LE 147 0 0 57659 2549
RE 147 2 2 54122 2716 LE 146 0 0 58440 2498
LE 144 0 0 55760 2582 RE 143 0 2 73228 1952
RE 145 2 2 54412 2664 LE 145 3 1 56824 2552
RE 146 0 1 60768 2403 LE 147 1 3 58780 2501
CS EyeOS Eye
NA
NA
NA
